7e4r

Publication Abstract from PubMed

Maytansinoids, the chemical derivatives of Maytansine, are commonly used as potent cytotoxic payloads in antibody-drug conjugates (ADC). Structure-activity-relationship studies had identified the C3 ester side chain as a critical element for antitumor activity of maytansinoids. The maytansinoids bearing the methyl group at C3 position with D configuration were about 100 to 400-fold less cytotoxic than their corresponding L-epimers toward various cell lines. The detailed mechanism of how chirality affects the anticancer activity remains elusive. In this study, we determined the high-resolution crystal structure of tubulin in complex with maytansinol, L-DM1-SMe and D-DM1-SMe. And we found the carbonyl oxygen atom of the ester moiety and the tail thiomethyl group at C3 side chain of L-DM1-SMe form strong intramolecular interaction with the hydroxyl at position 9 and the benzene ring, respectively, fixing the bioactive conformation and enhancing the binding affinity. Additionally, ligand-based and structure-based virtually screening methods were used to screen the commercially macrocyclic compounds library, and 15 macrocyclic structures were picketed out as putatively new maytansine-site inhibitors. Our study provides a possible strategy for the rational discovery of next-generation maytansine site inhibitors.

C3 ester side chain plays a pivotal role in the antitumor activity of Maytansinoids.,Li W, Huang M, Li Y, Xia A, Tan L, Zhang Z, Wang Y, Yang J Biochem Biophys Res Commun. 2021 Aug 20;566:197-203. doi: , 10.1016/j.bbrc.2021.05.071. Epub 2021 Jun 15. PMID:34144258^[4]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.